NCT05823883View on ClinicalTrials.gov

This Study is to Compare and Evaluate the Safety and Pharmacokinetic Characteristics (PK) After Administration of DW6014 and Each Component in Healthy Adult Volunteers in Fed Condition.

PHASE1UnknownINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 30, 2023

Primary Completion Date

July 31, 2023

Study Completion Date

August 31, 2023

Conditions

DW6014

Interventions

DRUG

DW6014

"Drug: DW6014 Single oral administration of DW6014 in fed condition~Drug: Empagliflozin and Metformin Combination oral administration of Empagliflozin and Metformin in fed condition"

Trial Locations (1)

Unknown

Chungbuk National University Hospital, Cheongju-si